• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFDA

FDA

Page 27 of 35
FDA Rejects Mylan’s Copycat of GSK’s Asthma Drug
HealthFDA Rejects Mylan’s Copycat of GSK’s Asthma Drug
By Sy MukherjeeMarch 29, 2017
The American Enterprise Institute photo of Scott Gottlieb
HealthTrump’s Nominee to Lead the FDA Got Paid Millions by the Health Care Industry
By Sy MukherjeeMarch 29, 2017
Walker For Handicapped Person
HealthThe FDA Just Approved the First Ever Drug to Treat Severe MS
By Sy MukherjeeMarch 29, 2017
Allergy Test, Child
HealthSanofi, Regeneron Win FDA Approval for Eczema Drug With Multi-Billion Dollar Potential
By Sy MukherjeeMarch 28, 2017
The American Enterprise Institute photo of Scott Gottlieb
HealthTrump Is Slashing FDA Rules. Why Isn’t Big Pharma Excited?
By Sy MukherjeeMarch 28, 2017
An FDA Program Incentivizing Rare Disease Drugs Will Be Investigated for Abuses
HealthAn FDA Program Incentivizing Rare Disease Drugs Will Be Investigated for Abuses
By Sy MukherjeeMarch 22, 2017
Pharmaceutical Production Inside Merck KGaA Health Care Laboratory
HealthPharma Executives Aren’t Excited About Trump’s Plans to Ease FDA Regulation
By ReutersMarch 13, 2017
Donald Trump Delivers Address To Joint Session Of Congress
HealthWhy Trump’s Emotional Plea for Fast Drug Approvals Will Split the Pharma Industry Apart
By Sy MukherjeeMarch 1, 2017
Gilead Just Paid $125 Million to Nab a Big Market Advantage
HealthGilead Just Paid $125 Million to Nab a Big Market Advantage
By Sy MukherjeeFebruary 21, 2017
CORRECTION-US-POLITICS-TRUMP-PHARMA
HealthWhy Drug Companies Don’t Want President Trump to Deregulate the FDA
By Sy MukherjeeFebruary 15, 2017
MN: Corporations In Minnesota
TechSt. Jude Releases Cyber Updates For Heart Devices After U.S. Probe
By ReutersJanuary 9, 2017
FRANCE-HEALTH-HOSPITAL
TechNew Rules Posted For Preventing Hacks on Heart Pacemakers
By ReutersDecember 27, 2016
Vitamin and Mineral pills
HealthWhy Did New Drug Approvals in the U.S. Plunge This Year?
By Sy MukherjeeDecember 15, 2016
Sarepta Therapeutics New Global Headquarters
HealthInsurers are Rebelling Against the FDA’s Most Controversial 2016 Drug Approval
By Sy MukherjeeDecember 14, 2016
483106863
HealthEverything You Need to Know About the Massive Health Reform Law That Just Passed Congress
By Sy MukherjeeDecember 7, 2016
1...
  • 25
  • 26
  • 27
  • 28
  • 29
...35
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.